To confirm the predictive value of targeted therapies for oncogenic driver gene mutations detected in malignant pleural effusion (MPE) cell blocks from patients with advanced non‐small cell lung cancer (NSCLC). Click to show full abstract
To confirm the predictive value of targeted therapies for oncogenic driver gene mutations detected in malignant pleural effusion (MPE) cell blocks from patients with advanced non‐small cell lung cancer (NSCLC).
               
Click one of the above tabs to view related content.